Evidence map›Paper›PMID 25162947›Full record

ArticleJournal of burn care & research : official publication of the American Burn Association

A multimodal assessment of melanin and melanocyte activity in abnormally pigmented hypertrophic scar.

Taryn E Travis, Pejhman Ghassemi, Jessica C Ramella-Roman, Nicholas J Prindeze, Dereck W Paul, Lauren T Moffatt, Marion H Jordan, Jeffrey W Shupp

Open access · greenAbstract read
In one paragraph

Article in Journal of burn care & research : official publication of the American Burn Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Chemiexcitation: Mammalian Photochemistry in the DarkPhotochemistry and photobiology · 2023
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. In-depth examination of hyperproliferative healing in two breeds ofAnimal models and experimental medicine · 2021
    Article
  13. [Research progress on the mechanism of wound skin dys- pigmentation after burns].Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns · 2021
    Review
  14. Article
  15. Article
  16. Dyspigmented hypertrophic scars: Beyond skin color.Pigment cell & melanoma research · 2019
    Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Taryn E TravisFrom the *Burn Center, Department of Surgery, MedStar Washington Hospital Center, MedStar Health Research Institute; †Department of Biomedical Engineering, Catholic University of America, Washington, District of Columbia; and ‡Department of Biomedical Engineering, Florida International University, Miami.
Pejhman Ghassemi
Jessica C Ramella-Roman
Nicholas J Prindeze
Dereck W Paul
Lauren T Moffatt
Marion H Jordan
Jeffrey W Shupp
MedStar Health · USCatholic University of America · USMedStar Washington Hospital Center · USFlorida International University · US

Funding

Novel Imaging System to Objectively Assess the Natural History of Treated and UntR15EB013439 · NIBIB · FLORIDA INTERNATIONAL UNIVERSITY · PI RAMELLA ROMAN, JESSICA C · 2011 to 2011
$409k
NIBIB NIH HHS R15 EB013439NIBIB NIH HHS R15EB013439
6 · The paper itself

Abstract

Using a validated swine model of human scar formation, hyperpigmented and hypopigmented scar samples were examined for their histological and optical properties to help elucidate the mechanisms and characteristics of dyspigmentation. Full-thickness wounds were created on the flanks of red Duroc pigs and allowed to heal. Biopsies from areas of hyperpigmentation, hypopigmentation, and uninjured tissue were fixed and embedded for histological examination using Azure B and primary antibodies to S100B, HMB45, and α-melanocyte-stimulating hormone (α-MSH). Spatial frequency domain imaging (SFDI) was then used to examine the optical properties of scars. Hyperpigmentation was first noticeable in healing wounds around weeks 2 to 3, gradually becoming darker. There was no significant difference in S100B staining for the presence of melanocytes between hyperpigmented and hypopigmented scar samples. Azure B staining of melanin was significantly greater in histological sections from hyperpigmented areas than in sections from both uninjured skin and hypopigmented scar (P < .0001). There was significantly greater staining for α-MSH in hyperpigmented samples compared with hypopigmented samples (P = .0121), and HMB45 staining was positive for melanocytes in hyperpigmented scar. SFDI at a wavelength of 632 nm resulted in an absorption coefficient map correlating with visibly hyperpigmented areas of scars. In a red Duroc model of hypertrophic scar formation, melanocyte number is similar in hyperpigmented and hypopigmented tissues. Hyperpigmented tissues, however, show a greater amount of melanin and α-MSH, along with immunohistochemical evidence of stimulated melanocytes. These observations encourage further investigation of melanocyte stimulation and the inflammatory environment within a wound that may influence melanocyte activity. Additionally, SFDI can be used to identify areas of melanin content in mature, pigmented scars, which may lead to its usefulness in wounds at earlier time points before markedly apparent pigmentation abnormalities.

Indexed as

alpha-MSHAnimalsCicatrix, HypertrophicDisease Models, AnimalHyperpigmentationHypopigmentationMaleMelaninsMelanocytesSwineWound Healingalpha-MSHMelanins

Identifiers

PMID25162947
PMCPMC4314717
OpenAlexW2312620443

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.